Related Experiment Video
Updated: Feb 21, 2026
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
18.8K
Patients' preferences for headache acute and preventive treatment
Dimos D Mitsikostas1, Ioanna Belesioti2, Chryssa Arvaniti3
1First Neurology Department, Aeginition Hospital, School of Medicine, National & Kapodistrian University of Athens, 72-74 V. Sofias' Avenue, 11528, Athens, Greece. dmitsikostas@med.uoa.gr.
The Journal of Headache and Pain
|October 8, 2017
Summary
Patients prioritize treatment efficacy over safety, favoring external neurostimulation devices and oral pills for headache management. Potential nocebo behaviors influenced these choices.
Area of Science:
- Neurology
- Patient-reported outcomes
- Treatment preferences
Background:
- Headache treatment decisions involve complex patient factors.
- Understanding patient preferences is crucial for effective management.
- Nocebo effects can influence treatment choices.
Purpose of the Study:
- To investigate patient preferences for headache treatments.
- To assess the influence of nocebo responses on treatment selection.
- To guide personalized headache therapy.
Main Methods:
- A self-administered questionnaire was used, including the Q-No questionnaire.
- Data were collected from 514 outpatients naive to specific advanced therapies.
- Patient preferences for efficacy, safety, and administration routes were evaluated.
Main Results:
- Efficacy was the primary factor in treatment selection over safety or administration route.
- External neurostimulation devices were preferred for acute and preventive care.
- Oral pills were favored for symptomatic and preventive pharmaceutical treatments.
- A significant portion of patients (56.6%) exhibited potential nocebo behaviors.
Conclusions:
- Patient preferences, particularly for efficacy and administration route, are key considerations.
- Nocebo behaviors may significantly impact treatment choices.
- Integrating patient preferences and nocebo awareness can optimize headache treatment strategies.
Related Concept Videos
01:25Analgesia and Pain Management
2.2K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.2K
01:30Preventive Healthcare Services
2.2K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
2.2K
01:29Venous Thrombosis III: Interprofessional Care
395
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
395
01:26Psychosis: Goals of Pharmacotherapy
620
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
620